This is not the most recent version of the article. View current version (20 JAN 2010)

Intervention Review

Ribavirin plus interferon versus interferon for chronic hepatitis C

  1. Jesper Brok*,
  2. Lise Lotte Gluud,
  3. Christian Gluud

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 7 FEB 2005

DOI: 10.1002/14651858.CD005445

Database Title

Additional Information

How to Cite

Brok J, Gluud LL, Gluud C. Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005445. DOI: 10.1002/14651858.CD005445.

Author Information

  1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Jesper Brok, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. jbrok@ctu.rh.dk. jesperb5@hotmail.com.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (20 Jan 2010)

View Full Article (HTML) Summary (58K)Standard (668K)Full (1050K)

  1. Current Version

    Ribavirin plus interferon versus interferon for chronic hepatitis C

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD005445.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Ribavirin plus interferon versus interferon for chronic hepatitis C

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD005445

View Full Article (HTML) Summary (58K)Standard (668K)Full (1050K)